blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2205258

EP2205258 - METHODS AND STRUCTURAL CONFORMATIONS OF ANTIBODY PREPARATIONS WITH INCREASED RESISTANCE TO PROTEASES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.03.2018
Database last updated on 14.03.2026
FormerThe patent has been granted
Status updated on  21.04.2017
FormerGrant of patent is intended
Status updated on  21.02.2017
Most recent event   Tooltip29.05.2020Lapse of the patent in a contracting state
New state(s): PT		published on 01.07.2020  [2020/27]
Applicant(s)For all designated states
Janssen Biotech, Inc.
800/850 Ridgeview Drive
Horsham, PA 19044 / US
[2011/44]
Former [2010/28]For all designated states
Centocor Ortho Biotech Inc.
800/850 Ridgeview Drive
Horsham, PA 19044 / US
Inventor(s)01 / RAJU, Shantha, T.
145 King Of Prussia Road
Radnor PA 19087 / US
02 / SCALLON, Bernard, J.
145 King Of Prussia Road
Radnor PA 19087 / US
 [2010/28]
Representative(s)Goodfellow, Hugh Robin
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2017/21]
Former [2010/28]Goodfellow, Hugh Robin
Carpmaels & Ransford 43-45 Bloomsbury Square London
WC1A 2RA / GB
Application number, filing date08836614.126.09.2008
[2010/28]
WO2008US77847
Priority number, dateUS20070976012P28.09.2007         Original published format: US 976012 P
[2010/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009045894
Date:09.04.2009
Language:EN
[2009/15]
Type: A1 Application with search report 
No.:EP2205258
Date:14.07.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 09.04.2009 takes the place of the publication of the European patent application.
[2010/28]
Type: B1 Patent specification 
No.:EP2205258
Date:24.05.2017
Language:EN
[2017/21]
Search report(s)International search report - published on:US09.04.2009
(Supplementary) European search report - dispatched on:EP25.04.2013
ClassificationIPC:A61K39/395, C07K16/00
[2013/21]
CPC:
C07K16/00 (EP,US); A61K39/39591 (EP,US); A61P35/00 (EP);
C07K2299/00 (EP,US); C07K2317/41 (EP,US); C07K2317/52 (EP,US)
Former IPC [2010/28]A61K38/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/21]
Former [2010/28]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:VERFAHREN UND STRUKTURKONFORMATIONEN VON ANTIKÖRPERZUBEREITUNGEN MIT ERHÖHTER RESISTENZ GEGENÜBER PROTEASEN[2010/28]
English:METHODS AND STRUCTURAL CONFORMATIONS OF ANTIBODY PREPARATIONS WITH INCREASED RESISTANCE TO PROTEASES[2010/28]
French:PROCÉDÉS ET CONFORMATIONS STRUCTURELLES DE PRÉPARATIONS D'ANTICORPS AVEC RÉSISTANCE ACCRUE AUX PROTÉASES[2010/28]
Entry into regional phase28.04.2010National basic fee paid 
28.04.2010Search fee paid 
28.04.2010Designation fee(s) paid 
28.04.2010Examination fee paid 
Examination procedure28.04.2010Amendment by applicant (claims and/or description)
28.04.2010Examination requested  [2010/28]
24.06.2015Despatch of a communication from the examining division (Time limit: M04)
04.11.2015Reply to a communication from the examining division
04.12.2015Despatch of a communication from the examining division (Time limit: M02)
25.01.2016Reply to a communication from the examining division
13.05.2016Despatch of a communication from the examining division (Time limit: M04)
21.09.2016Reply to a communication from the examining division
22.02.2017Communication of intention to grant the patent
11.04.2017Fee for grant paid
11.04.2017Fee for publishing/printing paid
11.04.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  24.06.2015
Opposition(s)27.02.2018No opposition filed within time limit [2018/18]
Fees paidRenewal fee
14.09.2010Renewal fee patent year 03
29.09.2011Renewal fee patent year 04
12.09.2012Renewal fee patent year 05
12.09.2013Renewal fee patent year 06
12.09.2014Renewal fee patent year 07
11.09.2015Renewal fee patent year 08
13.09.2016Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU26.09.2008
AT24.05.2017
CY24.05.2017
CZ24.05.2017
EE24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
PL24.05.2017
PT24.05.2017
RO24.05.2017
SI24.05.2017
SK24.05.2017
TR24.05.2017
BG24.08.2017
GR25.08.2017
LU26.09.2017
MT26.09.2017
[2020/27]
Former [2020/15]HU26.09.2008
AT24.05.2017
CY24.05.2017
CZ24.05.2017
EE24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
PL24.05.2017
RO24.05.2017
SI24.05.2017
SK24.05.2017
TR24.05.2017
BG24.08.2017
GR25.08.2017
LU26.09.2017
MT26.09.2017
Former [2019/46]HU26.09.2008
AT24.05.2017
CY24.05.2017
CZ24.05.2017
EE24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
PL24.05.2017
RO24.05.2017
SI24.05.2017
SK24.05.2017
BG24.08.2017
GR25.08.2017
LU26.09.2017
MT26.09.2017
Former [2019/31]HU26.09.2008
AT24.05.2017
CZ24.05.2017
EE24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
PL24.05.2017
RO24.05.2017
SI24.05.2017
SK24.05.2017
BG24.08.2017
GR25.08.2017
LU26.09.2017
MT26.09.2017
Former [2018/43]AT24.05.2017
CZ24.05.2017
EE24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
PL24.05.2017
RO24.05.2017
SI24.05.2017
SK24.05.2017
BG24.08.2017
GR25.08.2017
LU26.09.2017
MT26.09.2017
Former [2018/34]AT24.05.2017
CZ24.05.2017
EE24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
PL24.05.2017
RO24.05.2017
SI24.05.2017
SK24.05.2017
BG24.08.2017
GR25.08.2017
LU26.09.2017
Former [2018/25]AT24.05.2017
CZ24.05.2017
EE24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
PL24.05.2017
RO24.05.2017
SI24.05.2017
SK24.05.2017
BG24.08.2017
GR25.08.2017
Former [2018/11]AT24.05.2017
CZ24.05.2017
EE24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
PL24.05.2017
RO24.05.2017
SK24.05.2017
BG24.08.2017
GR25.08.2017
Former [2018/10]AT24.05.2017
CZ24.05.2017
EE24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
RO24.05.2017
SK24.05.2017
BG24.08.2017
GR25.08.2017
Former [2018/09]AT24.05.2017
EE24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
BG24.08.2017
GR25.08.2017
Former [2017/50]AT24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
LV24.05.2017
BG24.08.2017
GR25.08.2017
Former [2017/49]AT24.05.2017
FI24.05.2017
HR24.05.2017
LT24.05.2017
GR25.08.2017
Documents cited:Search[XY]   SANDER O ET AL: "Treatment of refractory rheumatoid arthritis with a tumor necrosis factor alpha receptor fusion protein (TNFR 55-IgG1): A monocentric observation in 80 patients", ZEITSCHRIFT FUER RHEUMATOLOGIE, vol. 57, no. 5, October 1998 (1998-10-01), pages 307 - 311, XP002692737, ISSN: 0340-1855 [X] 1-7,13-15 * the whole document * [Y] 8-12

DOI:   http://dx.doi.org/10.1007/s003930050117
 [Y]   RAJU T SHANTHA ET AL: "Fc glycans terminated with n-acetylglucosamine residues increase antibody resistance to papain", BIOTECHNOLOGY PROGRESS, vol. 23, no. 4, July 2007 (2007-07-01), pages 964 - 971, XP002692738, ISSN: 8756-7938 [Y] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1021/BP070118K
 [Y]   RAJU T S ET AL: "Glycosylation in the Fc domain of IgG increases resistance to proteolytic cleavage by papain", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 341, no. 3, 17 March 2006 (2006-03-17), pages 797 - 803, XP024923854, ISSN: 0006-291X, [retrieved on 20060317], DOI: 10.1016/J.BBRC.2006.01.030 [Y] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.bbrc.2006.01.030
 [Y]   GROENINK JASPER ET AL: "On the interaction between agalactosyl IgG and Fc-gamma receptors", EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 26, no. 6, 1996, pages 1404 - 1407, XP002692739, ISSN: 0014-2980 [Y] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1002/eji.1830260634
 [Y]   SENIOR BERNARD W ET AL: "Effect of mutations in the human immunoglobulin A1 (IgA1) hinge on its susceptibility to cleavage by diverse bacterial IgAl proteases", INFECTION AND IMMUNITY, vol. 73, no. 3, March 2005 (2005-03-01), pages 1515 - 1522, XP002692740, ISSN: 0019-9567 [Y] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1128/IAI.73.3.1515-1522.2005
 [Y]   RADAEV SERGEI ET AL: "Recognition of IgG by Fcgamma receptor. The role of Fc glycosylation and the binding of peptide inhibitors", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 276, no. 19, 11 May 2001 (2001-05-11), pages 16478 - 16483, XP002692741, ISSN: 0021-9258 [Y] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1074/JBC.M100351200
 [Y]   WORMALD ET AL: "Variations in oligosaccharide-Protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 36, 1 January 1997 (1997-01-01), pages 1370 - 1380, XP002096123, ISSN: 0006-2960, DOI: 10.1021/BI9621472 [Y] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1021/bi9621472
 [Y]   DWEK R A ET AL: "Glycobiology: 'the function of sugar in the IgG molecule'", JOURNAL OF ANATOMY, CAMBRIDGE UNIVERSITY PRESS, CAMBRIDGE, GB, vol. 187, 1 October 1995 (1995-10-01), pages 279 - 292, XP002096120, ISSN: 0021-8782 [Y] 1-15 * the whole document *
International search[Y]   KRAPP ET AL.: "Structural Analysis of Human IgG-Fc Glycoforms Reveals a Correlation Between Glycosylation and Structural Integrity.", J. MOL. BIOL., vol. 325, 2003, pages 979 - 989, XP004450000

DOI:   http://dx.doi.org/10.1016/S0022-2836(02)01250-0
 [A]   RUDD ET AL.: "Glycosylation and the Immune System.", CARBOHYDRATES AND GLYCOBIOLOGY, vol. 291, 2001, pages 2370 - 2376, XP008123586

DOI:   http://dx.doi.org/10.1126/science.291.5512.2370
by applicant  WRIGHT, A.; MORRISON, S. L., TRENDS BIOTECH., vol. 15, 1997, pages 26 - 32
   LIFELY, M. R. ET AL., GLYCOBIOLOGY, vol. 5, 1995, pages 813 - 822
   JEFFERIS, R. ET AL., IMMUNOL REV., vol. 163, 1998, pages 59 - 76
   RAJU, T.S. ET AL., GLYCOBIOLOGY, vol. 10, no. 5, 2000, pages 477 - 86
   MARUYAMA ET AL., BIOCHIM BIOPHYS ACTA, vol. 1234, 1995, pages 74 - 80
   DABKOWSKI ET AL., TRANSPLANT PROC., vol. 25, 1993, pages 2921
   YAMAMOTO ET AL., NATURE, vol. 345, 1990, pages 229 - 233
   VAN DEN EIJNDEN ET AL., J. BIOL. CHEM., vol. 256, 1981, pages 3159
   WEINSTEIN ET AL., J. BIOL. CHEM., vol. 257, 1982, pages 13845
   WEN ET AL., J. BIOL. CHEM., vol. 267, 1992, pages 21011
   REARICK ET AL., J. BIOL. CHEM., vol. 254, 1979, pages 4444
   GILLESPIE ET AL., J. BIOL. CHEM., vol. 267, 1992, pages 21004
   KUROSAWA ET AL., EUR. J. BIOCHEM., vol. 219, 1994, pages 375 - 381
   NAGATA ET AL., J. BIOL. CHEM., vol. 267, 1992, pages 12082 - 12089
   SMITH ET AL., J. BIOL CHEM., vol. 269, 1994, pages 15162
   HOMA ET AL., J. BIOL CHEM., vol. 268, 1993, pages 12609
   HULL ET AL., BBRC, vol. 176, 1991, pages 608
   IHARA ET AL., J. BIOLCHEM., vol. 113, 1993, pages 692
   SHOREIBAN ET AL., J. BIOL. CHEM., vol. 268, 1993, pages 15381
   ANUMULA, K. R.; DHUME ST., GLYCOBIOLOGY, vol. 8, no. 7, July 1998 (1998-07-01), pages 685 - 94
   RIPKA; STANLEY, SOMATIC CELL MOL GEN, vol. 12, 1986, pages 51 - 62
   "Current Protocols in Molecular Biology", 1987, JOHN WILEY & SONS, INC.
   SAMBROOK ET AL.: "Molecular Cloning: A Laboratory Manual", 1989, COLD SPRING HARBOR, NY
   HARLOW; LANE: "antibodies, a Laboratory Manual", 1989, COLD SPRING HARBOR, NY
   "Current Protocols in Immunology", 1994, JOHN WILEY & SONS, INC.
   COLLIGAN ET AL.: "Current Protocols in Protein Science", 1997, JOHN WILEY & SONS, NY, NY
   SMITH, G.P., SCIENCE, vol. 228, 1985, pages 1315 - 1317
   HOOGENBOOM ET AL., IMMUNOL. TODAY, vol. 21, no. 8, 2000, pages 371 - 8
   KRETZSCHMAR; VON RUDEN, CURRENT OPINION IN BIOTECHNOLOGY, vol. 13, 2000, pages 598 - 602
   MATTHEAKIS, L.C. ET AL., PROC. NATL. ACAD. SCI. USA, vol. 91, 1994, pages 9022
   BRODER ET AL., NATURE BIOTECHNOLOGY, vol. 15, 1997, pages 553 - 7
   CHEN; GEORGIOU, BIOTECHNOL BIOENG, vol. 79, 2002, pages 496 - 503
   ANUMULA KR., ANAL BIOCHEM., vol. 283, no. 1, 15 July 2000 (2000-07-15), pages 17 - 26
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.